In agreement with this result, we have shown previously that two Her2-postitive breast cancer cell lines SkBr3 and MDA-MB-453 are more responsive to PDT with ALA than MCF10A breast epithelial cells [11]. The gene discussed is ERBB2; the disease is breast carcinoma.